Home » Medical Devices » Canada Diabetes Care Devices Market

Canada Diabetes Care Devices Market By Type (Monitoring, Delivery); By Monitoring Devices (Continuous Monitoring Devices, Lancets, Test Strips, Self-Monitoring Devices); By Delivery Devices (Insulin Pumps, Pens, Syringes, Needles); By End-Users (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Indication (Diabetes Type I, Diabetes Type II, Gestational Diabetes) – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Summary
Table Of Content

REPORT ATTRIBUTE	DETAILS
Historical Period	2019-2022
Base Year	2023
Forecast Period	2024-2032
Canada Diabetes Care Devices market Size 2024	USD 1,209.55 million
Canada Diabetes Care Devices market, CAGR	7.86%
Canada Diabetes Care Devices market Size 2032	USD 2,469.97 million

Market Overview

The Canada Diabetes Care Devices market is projected to grow from USD 1,209.55 million in 2023 to USD 2,469.97 million by 2032, at a compound annual growth rate (CAGR) of 7.86%.

The Canada Diabetes Care Devices market is driven by the increasing prevalence of diabetes, rising awareness about diabetes management, and advancements in technology. With a growing aging population and an increase in lifestyle-related diseases, the demand for effective diabetes care solutions is rising. Innovations such as continuous glucose monitoring (CGM) systems, insulin pumps, and advanced diagnostic tools are further fueling market growth. Additionally, government initiatives aimed at improving healthcare access and promoting early diabetes detection contribute to the expansion of the market. Trends include the shift towards non-invasive and minimally invasive devices, as well as the integration of mobile apps and cloud technology for real-time data tracking and management. The rising preference for personalized and connected healthcare solutions also supports the demand for smart diabetes devices, offering patients greater control and convenience in managing their condition.

The Canadian diabetes care devices market is characterized by regional variations in demand, with key growth regions including Ontario, Quebec, and British Columbia. Ontario leads in the adoption of advanced diabetes care technologies due to its large population and well-developed healthcare infrastructure. Quebec follows with steady growth, driven by public health initiatives and government-funded programs that improve access to diabetes management solutions. British Columbia, known for its progressive healthcare system, is also witnessing increased adoption of continuous glucose monitoring (CGM) systems and insulin pumps. Key players in the market include Abbott Laboratories, Medtronic, Roche Diagnostics, and Dexcom, who lead the market with their advanced glucose monitoring systems and insulin pumps. These companies are continually innovating to offer more efficient, accurate, and user-friendly devices to cater to the growing demand for diabetes management solutions across Canada. Their ongoing partnerships with healthcare providers further enhance market accessibility.

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

Market Insights

The Canadian diabetes care devices market was valued at USD 1,209.55 million in 2023 and is expected to reach USD 2,469.97 million by 2032, growing at a CAGR of 7.86%.
Increasing prevalence of diabetes, driven by rising cases of type 2 diabetes and an aging population, is a key market driver.
Growing awareness about diabetes management, fueled by public health campaigns and better patient education, supports market expansion.
Technological advancements such as continuous glucose monitoring (CGM) systems and insulin pumps are propelling market growth.
High costs of advanced devices, like CGM systems and insulin pumps, remain a significant market restraint.
Limited access to specialized care in rural regions hinders optimal usage of diabetes care devices.
Ontario and Quebec are the dominant regions, with Ontario holding the largest market share due to its advanced healthcare infrastructure and high diabetes prevalence.

Market Drivers

Increasing Prevalence of Diabetes

The rising incidence of type 2 diabetes is one of the key drivers of the diabetes care devices market in Canada. Factors such as sedentary lifestyles, obesity, and poor dietary habits are contributing to the increased number of individuals diagnosed with the condition. For instance, the Public Health Agency of Canada reports that approximately 3.7 million Canadians were living with diagnosed diabetes in 2020-2021. Additionally, the aging population is more vulnerable to developing type 2 diabetes, further amplifying the need for effective diabetes management solutions. As the number of diabetic patients grows, the demand for devices that aid in monitoring and controlling blood sugar levels continues to rise, propelling market growth.

Growing Awareness of Diabetes and Its Management

Raising awareness about diabetes and its management is essential for controlling the disease’s impact. Increased public health campaigns have been crucial in educating the public about the risks, symptoms, and treatment options for diabetes. For instance, Diabetes Canada runs various awareness campaigns and educational programs to inform the public about diabetes management. Furthermore, improved patient education has led to a better understanding of the importance of regular monitoring, timely treatment, and lifestyle adjustments. As patients become more informed, they are more likely to invest in advanced diabetes care devices that enable them to manage their condition effectively, driving demand for innovative solutions.

Technological Advancements

Technological innovation plays a pivotal role in shaping the Canada diabetes care devices market. Continuous glucose monitoring (CGM) systems have revolutionized diabetes management by providing real-time glucose levels, enabling patients to make informed decisions about insulin dosing and lifestyle modifications. Insulin pump therapy is also gaining popularity, offering automated insulin delivery to improve glycemic control and reduce the burden of daily injections. Additionally, the growing integration of smart devices and mobile apps in diabetes care allows for remote monitoring, seamless data sharing with healthcare providers, and personalized diabetes management, further driving the market forward.

Supportive Government Initiatives

Government initiatives have played a significant role in improving access to diabetes care devices in Canada. Reimbursement policies, including government programs and insurance coverage, have made diabetes care devices more affordable for patients. For instance, the Canadian government has introduced a national framework for diabetes, which includes measures to improve access to diabetes care devices. Public health initiatives, often funded by the government, have helped raise awareness about diabetes prevention and management, encouraging the adoption of advanced diabetes care technologies. These supportive policies are essential in ensuring that patients can access the latest devices, thereby fostering market growth and improving diabetes care across the country.

Focus on Personalized Medicine

Personalized medicine is gaining traction in diabetes management, with healthcare providers increasingly focusing on tailored treatment plans for individual patients. This approach often involves the use of advanced devices such as CGMs, insulin pumps, and smart monitoring systems. By offering solutions that are specifically designed to meet the unique needs of each patient, personalized medicine is enhancing the effectiveness of diabetes care. This growing emphasis on individualized care is expected to further drive demand for innovative diabetes care devices in the Canadian market.

Market Trends

Increasing Adoption of Advanced Diabetes Care Devices

The demand for continuous glucose monitoring (CGM) systems is increasing as these devices provide real-time glucose data, allowing patients to make timely adjustments to their treatment plans. For instance, the adoption of CGM technology among children with Type 1 diabetes has significantly increased, with usage rising from 4% to 51% in those younger than 6 years over an eight-year period. The advancements in CGM technology, such as longer-lasting sensors and enhanced accuracy, are further accelerating market growth. Additionally, the growing adoption of insulin pumps is playing a crucial role in this trend. Insulin pumps offer precise insulin delivery, reducing the need for multiple daily injections, and improving glycemic control. The development of automated insulin delivery systems, which combine CGM with insulin pump technology, is also contributing to the market expansion. These systems offer a more seamless, efficient solution for managing diabetes, making them highly popular among patients and healthcare providers alike. This combination of innovations is driving the demand for advanced diabetes care devices, with CGMs and insulin pumps becoming integral components of modern diabetes management.

Technological Advancements and Supportive Government Policies

Telehealth and remote monitoring solutions, which gained prominence during the COVID-19 pandemic, are significantly impacting the diabetes care landscape. These technologies enable patients to connect with healthcare providers remotely, improving access to care and reducing the burden of in-person visits. This shift toward remote diabetes management has contributed to the growing adoption of digital health solutions. Furthermore, the trend towards personalized medicine is another key factor in driving market growth. Healthcare providers are focusing on tailoring treatment plans to individual patient needs, which is spurring the development of advanced diabetes devices that offer customized insights and recommendations. Additionally, government initiatives and favorable reimbursement policies are making diabetes care devices more accessible. These policies reduce the financial burden on patients and encourage the widespread adoption of these devices, ensuring that more individuals can access the tools necessary for effective diabetes management. Together, these trends are reshaping the diabetes care market, making it more patient-centric and technologically advanced.

Market Challenges Analysis

High Costs and Reimbursement Barriers

The high cost of advanced diabetes care devices, such as continuous glucose monitoring (CGM) systems and insulin pumps, remains a significant challenge in the market. These devices offer valuable benefits in managing diabetes, but their expensive price tags often make them inaccessible to many patients, particularly those with limited insurance coverage. For instance, an American Diabetes Association survey found that 1 in 5 people with diabetes have foregone or delayed getting a CGM or insulin pump due to financial strain. This financial barrier hinders the adoption of life-improving technologies, leaving many individuals without the necessary tools to manage their condition effectively. While government programs and insurance plans may offer partial coverage, the reimbursement process can be complex and time-consuming. Changes in reimbursement policies can further complicate access, affecting the availability and affordability of these devices. As a result, the reimbursement challenges faced by patients and healthcare providers are contributing to slower adoption rates and limiting the overall reach of advanced diabetes care devices.

Access and Usability Challenges

Limited access to specialized diabetes care is another challenge that impacts device usage and patient outcomes. In rural or underserved regions, access to healthcare professionals, such as diabetes educators and endocrinologists, may be scarce, limiting the support patients receive in using advanced devices. This lack of access can prevent patients from learning how to use these devices optimally, leading to suboptimal health outcomes. Additionally, the complexity of some diabetes devices, particularly insulin pumps and advanced CGM systems, can be a barrier to proper use. These devices require extensive training to ensure correct operation, and user errors—such as incorrect device settings or improper insulin dosing—can lead to adverse health outcomes. Moreover, the growing reliance on digital technology in diabetes devices raises concerns about data privacy and security. Ensuring the confidentiality of patient information is crucial to building trust and encouraging adoption. Finally, the durability of these devices poses another challenge. Wearable sensors and other components can be prone to damage, requiring regular maintenance and costly replacements, which adds to the overall cost of device ownership. These factors collectively hinder the widespread adoption and effective use of diabetes care devices, presenting challenges that need to be addressed for the market to reach its full potential.

Market Opportunities

Rising Demand for Advanced Diabetes Management Solutions

The increasing prevalence of diabetes in Canada presents significant market opportunities for the diabetes care devices sector. As the number of diabetes cases rises due to factors like aging populations, sedentary lifestyles, and poor dietary habits, the demand for advanced management solutions such as continuous glucose monitoring (CGM) systems and insulin pumps continues to grow. These technologies provide patients with real-time data, allowing for more precise insulin dosing and lifestyle adjustments. With further technological advancements in device accuracy, longer-lasting sensors, and integration with mobile apps, there is an opportunity to expand the market reach. The demand for personalized medicine and customized treatment plans also opens avenues for developing innovative solutions tailored to individual patient needs, thereby improving patient outcomes and driving market growth.

Government Support and Reimbursement Policies

Government initiatives aimed at improving healthcare access and increasing diabetes awareness present additional opportunities in the Canadian diabetes care devices market. Government-funded public health programs, combined with favorable reimbursement policies for diabetes care devices, can help reduce the financial burden on patients, making these devices more accessible to a broader population. As policies evolve to support more inclusive healthcare, the market has the potential for further expansion. Furthermore, the rise of telehealth and remote monitoring technologies, accelerated by the COVID-19 pandemic, provides opportunities for companies to innovate and integrate digital health solutions, making diabetes care more accessible and convenient for patients. This shift toward remote care and digital health platforms, coupled with increased adoption of smart devices, offers a strong growth trajectory for the Canadian diabetes care devices market.

Market Segmentation Analysis:

By Type:

The Canada Diabetes Care Devices market can be broadly categorized into two key segments: monitoring devices and delivery devices. Monitoring devices are crucial for tracking blood glucose levels and providing data for managing diabetes. This segment includes continuous monitoring devices, lancets, test strips, and self-monitoring devices. Continuous glucose monitoring (CGM) devices are gaining popularity for their ability to provide real-time data, empowering patients to make timely adjustments to their insulin dosages and lifestyle. Self-monitoring devices, such as blood glucose meters, are also widely used, allowing patients to check their glucose levels at home. Lancets and test strips remain essential components of traditional glucose monitoring systems, though their role is increasingly being supplemented by more advanced technologies. The delivery devices segment includes insulin pumps, which provide precise insulin delivery to patients with diabetes, reducing the need for multiple injections and improving overall glycemic control. The combination of these two segments allows for comprehensive diabetes management, and both are expected to witness significant growth as the demand for better treatment solutions rises.

By Monitoring Devices:

The monitoring devices segment holds a dominant share in the Canadian diabetes care market, driven by the increasing adoption of continuous glucose monitoring (CGM) systems and self-monitoring devices. CGMs offer real-time glucose tracking, making them essential for patients who need constant monitoring and personalized insulin adjustments. These systems not only improve glycemic control but also reduce the risk of complications associated with diabetes. Self-monitoring devices, such as portable glucose meters, continue to play a significant role in diabetes care, providing patients with the ability to track their glucose levels at home. Lancets and test strips, while less advanced than CGMs, remain in high demand due to their cost-effectiveness and reliability. However, as more people seek technologically advanced solutions, the CGM and self-monitoring segments are expected to see substantial growth. The demand for delivery devices like insulin pumps is also on the rise, as they offer greater convenience and precision in insulin administration, further driving the overall market growth for diabetes care devices in Canada.

Segments:

Based on Type:

Monitoring
Delivery

Based on Monitoring Devices:

Continuous Monitoring Devices
Lancets
Test Strips
Self Monitoring Devices

Based on Delivery Devices:

Insulin Pumps
Pens
Syringes
Needles

Based on End-Users:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Based on Indication:

Diabetes Type I
Diabetes Type II
Gestational Diabetes

Based on the Geography:

Ontario
Quebec
Western Canada
British Columbia
Atlantic Canada

Regional Analysis

Ontario

Ontario holds the largest market share in the Canada Diabetes Care Devices market, representing approximately 38% of the overall demand. This is due to the province’s large population, which has a high prevalence of diabetes, and its robust healthcare infrastructure, which facilitates the adoption of advanced diabetes care technologies. The demand for continuous glucose monitoring (CGM) systems, insulin pumps, and self-monitoring devices is particularly strong in Ontario’s urban centers, such as Toronto and Ottawa. These devices are widely supported by provincial healthcare programs and insurance coverage, ensuring greater accessibility. As the number of individuals living with diabetes continues to rise in Ontario, the market for diabetes care devices is expected to expand further. Quebec follows as the second-largest market, holding a market share of around 26%. The province has seen a steady increase in diabetes cases, especially in regions like Montreal and Quebec City. Quebec’s public healthcare system and government-funded programs have been crucial in making diabetes care devices more accessible to the population. Although Quebec’s market share is smaller than Ontario’s, the adoption of diabetes management devices is growing, fueled by increasing awareness and healthcare initiatives targeting diabetes care.

Western Canada and British Columbia
Western Canada, encompassing provinces like Manitoba, Saskatchewan, and Alberta, represents approximately 20% of the overall market for diabetes care devices in Canada. The region is witnessing a rise in the prevalence of diabetes, particularly in urban centers like Calgary and Edmonton. However, its market share is slightly smaller compared to Ontario and Quebec due to factors like a smaller population and less comprehensive healthcare infrastructure. Still, the demand for diabetes care devices, especially CGM systems and insulin pumps, is increasing as healthcare access improves. British Columbia, in particular, plays a key role within Western Canada, holding a market share of around 15%. The province is known for its progressive approach to healthcare, with government programs that support the use of advanced diabetes care devices. British Columbia’s population, which is highly engaged in health and wellness, is increasingly adopting devices like CGMs and insulin pumps, further driving market growth. The market in British Columbia is expected to continue expanding due to the growing awareness of diabetes management technologies and supportive healthcare policies.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Key Player Analysis

Abbott Laboratories
ACON Laboratories, Inc.
Ascensia Diabetes Care Holdings AG
Becton, Dickinson and Company
Dexcom, Inc.
Hoffmann-La Roche Ltd
Johnson & Johnson
Medtronic plc
Novo Nordisk A/S
Terumo Corporation
Company 11
Company 12
Company 13
Company 14

Competitive Analysis

The Canada diabetes care devices market is highly competitive, with several leading players driving innovation and shaping market dynamics. Key players include Abbott Laboratories, Medtronic, Roche Diagnostics, Dexcom, Johnson & Johnson, and Bayer Healthcare. These companies are focused on providing advanced solutions such as continuous glucose monitoring (CGM) systems and insulin pumps that help manage diabetes more effectively. The market is driven by technological advancements, with key players investing heavily in research and development to improve the functionality, accuracy, and ease of use of their devices. The increasing demand for devices that provide real-time glucose monitoring and automated insulin delivery is shaping the competitive landscape. In addition to technological innovations, companies are also focusing on expanding their product portfolios to cater to the growing demand for personalized diabetes care. Many players are forging partnerships with healthcare providers to enhance device accessibility and integration with mobile applications for better patient management. Favorable reimbursement policies and government initiatives have played a crucial role in improving market access. The competition remains fierce, as players strive to capture market share by offering cost-effective and user-friendly solutions that meet the needs of the growing diabetic population in Canada.

Recent Developments

In October 2024, Glooko secured a USD 100 million investment aimed at expanding its diabetes management system. The funding was intended to enhance the company’s reach across North America, as well as the Middle East and Asia.
In August 2024, Medtronic announced its partnership with Abbott, which was expected to improve its struggling diabetes care segment by integrating advanced glucose monitoring technology, enhancing their offerings and potentially strengthening Medtronic’s position in the market.
In March 2024, Dexcom introduced its newest CGM system, Dexcom ONE+, in Ireland. Dexcom ONE+ utilizes Dexcom’s top-tier and highly accurate sensor design. This product launch will bolster the company’s product portfolio in the Irish market and is expected to boost the company’s revenue.
In May 2023, Medtronic agreed to acquire EOFlow, a manufacturer of insulin devices. The integration of EOFlow with Medtronic’s Meal Detection Technology algorithm and advanced continuous glucose monitor (CGM) is expected to enhance the company’s ability to serve a broader range of people with diabetes
In April 2023, Undbio announced its plan to invest USD 100 million in constructing a US-based insulin manufacturing plant. The South Korean company intends to build a new facility in West Virginia to manufacture insulin and distribute its products within the country
In July 2023, CharmHealth and Bioverge jointly invested in My Diabetes Tutor, a startup focused on improving the lives of individuals with diabetes

Market Concentration & Characteristics

The market concentration of Canada’s diabetes care devices sector is relatively moderate, with several key players holding significant shares, yet leaving room for smaller companies and innovative startups to compete. The industry is characterized by a few dominant companies that lead in advanced technologies such as continuous glucose monitoring (CGM) systems and insulin pumps. These established players benefit from strong brand recognition, extensive distribution networks, and substantial investments in research and development. However, there is increasing competition from smaller, innovative firms that focus on niche solutions or offer cost-effective alternatives to traditional devices. The market is also marked by a high degree of technological advancement, with devices becoming more user-friendly, accurate, and integrated with digital platforms for better patient management. The shift toward personalized diabetes care, powered by smart devices and mobile apps, is another key feature, driving further competition and innovation. Additionally, government policies, such as favorable reimbursement options, have reduced entry barriers for new entrants while supporting the growth of established companies. The market’s growth is fueled by increasing awareness of diabetes management, a rising diabetic population, and a shift toward more advanced, connected devices. As the market evolves, it will likely see greater consolidation among the larger players, though smaller firms with innovative solutions will continue to drive competition.

Report Coverage

The research report offers an in-depth analysis based on Type, Monitoring Devices, Delivery Devices, Indication, End-Users and Geography. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook

The growing focus on personalized medicine will lead to more tailored diabetes management solutions, enhancing treatment effectiveness.
Partnerships between healthcare providers and diabetes device manufacturers will strengthen, improving patient education and device integration.
The demand for wearable diabetes care devices will rise as patients seek more discreet, convenient, and comfortable monitoring solutions.
Advances in sensor technology will lead to longer-lasting and more accurate glucose monitoring systems.
The market will see increased investment in artificial intelligence and machine learning to improve device functionality and predictive analytics for diabetes management.
Global expansion of Canadian diabetes care device manufacturers will open up new growth opportunities in international markets.
As diabetes awareness campaigns grow, more individuals will seek early diagnosis and adopt proactive diabetes management tools.
Environmental concerns and the push for sustainability will drive the development of eco-friendly, recyclable diabetes care devices.
Device interoperability will improve, allowing for seamless integration with other healthcare technologies and enhancing overall patient care.
The rise in healthcare digitalization will foster the development of remote patient monitoring and telehealth solutions for better diabetes care management.

CHAPTER NO. 1 : INTRODUCTION 21

1.1.1. Report Description 21

Purpose of the Report 21

USP & Key Offerings 21

1.1.2. Key Benefits for Stakeholders 21

1.1.3. Target Audience 22

1.1.4. Report Scope 22

CHAPTER NO. 2 : EXECUTIVE SUMMARY 23

2.1. DIABETES CARE DEVICES Market Snapshot 23

2.1.1. Canada DIABETES CARE DEVICES Market, 2018 – 2032 (USD Million) 24

CHAPTER NO. 3 : GEOPOLITICAL CRISIS IMPACT ANALYSIS 25

3.1. Canada-Ukraine and Israel-Palestine War Impacts 25

CHAPTER NO. 4 : DIABETES CARE DEVICES MARKET – INDUSTRY ANALYSIS 26

4.1. Introduction 26

4.2. Market Drivers 27

4.2.1. Rising Prevalnce of Diabetes 27

4.2.2. Unhealthy life style and habits increasing the risks of Diabetes 28

4.3. Market Restraints 29

4.3.1. Invasive technologies increasing the risk of infection 29

4.4. Market Opportunities 30

4.4.1. Market Opportunity Analysis 30

4.5. Porter’s Five Forces Analysis 31

4.6. Value Chain Analysis 32

4.7. Buying Criteria 33

CHAPTER NO. 5 : IMPORT EXPORT ANALYSIS 34

5.1. Import Analysis by Canada 34

5.1.1. Canada DIABETES CARE DEVICES Market Import Volume/Revenue, By Canada, 2018 – 2023 34

5.2. Export Analysis by Canada 35

5.2.1. Canada DIABETES CARE DEVICES Market Export Volume/Revenue, By Canada, 2018 – 2023 35

CHAPTER NO. 6 : DEMAND SUPPLY ANALYSIS 36

6.1. Demand Analysis by Canada 36

6.1.1. Canada DIABETES CARE DEVICES Market Demand Volume/Revenue, By Canada, 2018 – 2023 36

6.2. Supply Analysis by Canada 37

6.2.1. Canada DIABETES CARE DEVICES Market Supply Volume/Revenue, By Canada, 2018 – 2023 37

CHAPTER NO. 7 : PRODUCTION ANALYSIS 38

7.1. Production Analysis by Canada 38

7.1.1. Canada DIABETES CARE DEVICES Market Production Volume/Revenue, By Canada, 2018 – 2023 38

CHAPTER NO. 8 : PRICE ANALYSIS 39

8.1. Price Analysis by Type 39

8.1.1. Canada DIABETES CARE DEVICES Market Price, By Type, 2018 – 2023 39

8.1.2. Canada Type Market Price, By Type, 2018 – 2023 39

CHAPTER NO. 9 : RAW MATERIALS ANALYSIS 40

9.1. Key Raw Materials and Suppliers 40

9.2. Key Raw Materials Price Trend 40

CHAPTER NO. 10 : MANUFACTURING COST ANALYSIS 41

10.1. Manufacturing Cost Analysis 41

10.2. Manufacturing Process 41

CHAPTER NO. 11 : ANALYSIS COMPETITIVE LANDSCAPE 42

11.1. Company Market Share Analysis – 2023 42

11.1.1. Canada DIABETES CARE DEVICES Market: Company Market Share, by Volume, 2023 42

11.1.2. Canada DIABETES CARE DEVICES Market: Company Market Share, by Revenue, 2023 43

11.1.3. Canada DIABETES CARE DEVICES Market: Top 6 Company Market Share, by Revenue, 2023 43

11.1.4. Canada DIABETES CARE DEVICES Market: Top 3 Company Market Share, by Revenue, 2023 44

11.2. Canada DIABETES CARE DEVICES Market Company Volume Market Share, 2023 45

11.3. Canada DIABETES CARE DEVICES Market Company Revenue Market Share, 2023 46

11.4. Company Assessment Metrics, 2023 47

11.4.1. Stars 47

11.4.2. Emerging Leaders 47

11.4.3. Pervasive Players 47

11.4.4. Participants 47

11.5. Start-ups /SMEs Assessment Metrics, 2023 47

11.5.1. Progressive Companies 47

11.5.2. Responsive Companies 47

11.5.3. Dynamic Companies 47

11.5.4. Starting Blocks 47

11.6. Strategic Developments 48

11.6.1. Acquisitions & Mergers 48

New Product Launch 48

Canada Expansion 48

11.7. Key Players Product Matrix 49

CHAPTER NO. 12 : PESTEL & ADJACENT MARKET ANALYSIS 50

12.1. PESTEL 50

12.1.1. Political Factors 50

12.1.2. Economic Factors 50

12.1.3. Social Factors 50

12.1.4. Technological Factors 50

12.1.5. Environmental Factors 50

12.1.6. Legal Factors 50

12.2. Adjacent Market Analysis 50

CHAPTER NO. 13 : DIABETES CARE DEVICES MARKET – BY TYPE SEGMENT ANALYSIS 51

13.1. DIABETES CARE DEVICES Market Overview, by Type Segment 51

13.1.1. DIABETES CARE DEVICES Market Revenue Share, By Type, 2023 & 2032 52

13.1.2. DIABETES CARE DEVICES Market Attractiveness Analysis, By Type 53

13.1.3. Incremental Revenue Growth Opportunity, by Type, 2024 – 2032 53

13.1.4. DIABETES CARE DEVICES Market Revenue, By Type, 2018, 2023, 2027 & 2032 54

13.2. Monitoring 55

13.3. Delivery 56

CHAPTER NO. 14 : DIABETES CARE DEVICES MARKET – BY MONITORING DEVICES SEGMENT ANALYSIS 57

14.1. DIABETES CARE DEVICES Market Overview, by Monitoring Devices Segment 57

14.1.1. DIABETES CARE DEVICES Market Revenue Share, By Monitoring Devices , 2023 & 2032 58

14.1.2. DIABETES CARE DEVICES Market Attractiveness Analysis, By Monitoring Devices 59

14.1.3. Incremental Revenue Growth Opportunity, by Monitoring Devices , 2024 – 2032 59

14.1.4. DIABETES CARE DEVICES Market Revenue, By Monitoring Devices , 2018, 2023, 2027 & 2032 60

14.2. Continuous Monitoring Devices 61

14.3. Lancets 62

14.4. Test Strips 63

14.5. Self Monitoring Devices 64

CHAPTER NO. 15 : DIABETES CARE DEVICES MARKET – BY DELIVERY DEVICES SEGMENT ANALYSIS 65

15.1. DIABETES CARE DEVICES Market Overview, by Delivery Devices Segment 65

15.1.1. DIABETES CARE DEVICES Market Revenue Share, By Delivery Devices , 2023 & 2032 66

15.1.2. DIABETES CARE DEVICES Market Attractiveness Analysis, By Delivery Devices 67

15.1.3. Incremental Revenue Growth Opportunity, by Delivery Devices , 2024 – 2032 67

15.1.4. DIABETES CARE DEVICES Market Revenue, By Delivery Devices , 2018, 2023, 2027 & 2032 68

15.2. Insulin Pumps 69

15.3. Pens 70

15.4. Syringes 71

15.5. Needles 72

CHAPTER NO. 16 : DIABETES CARE DEVICES MARKET – BY END-USERS SEGMENT ANALYSIS 73

16.1. DIABETES CARE DEVICES Market Overview, by End-Users Segment 73

16.1.1. DIABETES CARE DEVICES Market Revenue Share, By End-Users, 2023 & 2032 74

16.1.2. DIABETES CARE DEVICES Market Attractiveness Analysis, By End-Users 75

16.1.3. Incremental Revenue Growth Opportunity, by End-Users, 2024 – 2032 75

16.1.4. DIABETES CARE DEVICES Market Revenue, By End-Users, 2018, 2023, 2027 & 2032 76

16.2. Hospital Pharmacies 77

16.3. Retail Pharmacies 78

16.4. Online Pharmacies 79

CHAPTER NO. 17 : DIABETES CARE DEVICES MARKET – BY INDICATION CHANNEL SEGMENT ANALYSIS 80

17.1. DIABETES CARE DEVICES Market Overview, by Indication Channel Segment 80

17.1.1. DIABETES CARE DEVICES Market Revenue Share, By Indication Channel, 2023 & 2032 81

17.1.2. DIABETES CARE DEVICES Market Attractiveness Analysis, By Indication Channel 82

17.1.3. Incremental Revenue Growth Opportunity, by Indication Channel, 2024 – 2032 82

17.1.4. DIABETES CARE DEVICES Market Revenue, By Indication Channel, 2018, 2023, 2027 & 2032 83

17.2. Diabetes Type I 84

17.3. Diabetes Type II 85

17.4. Gestational Diabetes 86

CHAPTER NO. 18 : DIABETES CARE DEVICES MARKET – CANADA ANALYSIS 87

18.1. Type 87

18.1.1. Canada DIABETES CARE DEVICES Market Revenue, By Type, 2018 – 2023 (USD Million) 87

18.2. Canada DIABETES CARE DEVICES Market Revenue, By Type, 2024 – 2032 (USD Million) 87

18.3. Monitoring Devices 88

18.3.1. Canada DIABETES CARE DEVICES Market Revenue, By Monitoring Devices , 2018 – 2023 (USD Million) 88

18.3.2. Canada DIABETES CARE DEVICES Market Revenue, By Monitoring Devices , 2024 – 2032 (USD Million) 88

18.4. Delivery Devices 89

18.4.1. Canada DIABETES CARE DEVICES Market Revenue, By Delivery Devices , 2018 – 2023 (USD Million) 89

18.4.2. Canada DIABETES CARE DEVICES Market Revenue, By Delivery Devices , 2024 – 2032 (USD Million) 89

18.5. End-Users 90

18.5.1. Canada DIABETES CARE DEVICES Market Revenue, By End-Users, 2018 – 2023 (USD Million) 90

18.5.2. Canada DIABETES CARE DEVICES Market Revenue, By End-Users, 2024 – 2032 (USD Million) 90

18.6. Indication Channel 91

18.6.1. Canada DIABETES CARE DEVICES Market Revenue, By Indication Channel, 2018 – 2023 (USD Million) 91

18.6.2. Canada DIABETES CARE DEVICES Market Revenue, By Indication Channel, 2024 – 2032 (USD Million) 91

CHAPTER NO. 19 : COMPANY PROFILES 92

19.1. Abbott Laboratories 92

19.1.1. Company Overview 92

19.1.2. Product Portfolio 92

19.1.3. Swot Analysis 92

19.1.4. Business Strategy 93

19.1.5. Financial Overview 93

19.2. ACON Laboratories, Inc. 94

19.3. Ascensia Diabetes Care Holdings AG 94

19.4. Becton, Dickinson and Company 94

19.5. Dexcom, Inc. 94

19.6. F. Hoffmann-La Roche Ltd 94

19.7. Johnson & Johnson 94

19.8. Medtronic plc 94

19.9. Novo Nordisk A/S 94

19.10. INSULET CANADA CORPORATION 94

19.11. Company 11 94

19.12. Company 12 94

19.13. Company 13 94

19.14. Company 14 94

List of Figures

FIG NO. 1. Canada DIABETES CARE DEVICES Market Revenue, 2018 – 2032 (USD Million) 22

FIG NO. 2. Porter’s Five Forces Analysis for Canada DIABETES CARE DEVICES Market 29

FIG NO. 3. Value Chain Analysis for Canada DIABETES CARE DEVICES Market 30

FIG NO. 4. Canada DIABETES CARE DEVICES Market Import Volume/Revenue, By Canada, 2018 – 2023 32

FIG NO. 5. Canada DIABETES CARE DEVICES Market Export Volume/Revenue, By Canada, 2018 – 2023 33

FIG NO. 6. Canada DIABETES CARE DEVICES Market Demand Volume/Revenue, By Canada, 2018 – 2023 34

FIG NO. 7. Canada DIABETES CARE DEVICES Market Supply Volume/Revenue, By Canada, 2018 – 2023 35

FIG NO. 8. Canada DIABETES CARE DEVICES Market Production Volume/Revenue, By Canada, 2018 – 2023 36

FIG NO. 9. Canada DIABETES CARE DEVICES Market Price, By Type, 2018 – 2023 37

FIG NO. 10. Raw Materials Price Trend Analysis, 2018 – 2023 38

FIG NO. 11. Manufacturing Cost Analysis 39

FIG NO. 12. Manufacturing Process 39

FIG NO. 13. Company Share Analysis, 2023 40

FIG NO. 14. Company Share Analysis, 2023 41

FIG NO. 15. Company Share Analysis, 2023 41

FIG NO. 16. Company Share Analysis, 2023 42

FIG NO. 17. DIABETES CARE DEVICES Market – Company Volume Market Share, 2023 43

FIG NO. 18. DIABETES CARE DEVICES Market – Company Revenue Market Share, 2023 44

FIG NO. 19. DIABETES CARE DEVICES Market Revenue Share, By Type, 2023 & 2032 50

FIG NO. 20. Market Attractiveness Analysis, By Type 51

FIG NO. 21. Incremental Revenue Growth Opportunity by Type, 2024 – 2032 51

FIG NO. 22. DIABETES CARE DEVICES Market Revenue, By Type, 2018, 2023, 2027 & 2032 52

FIG NO. 23. Canada DIABETES CARE DEVICES Market for Monitoring, Revenue (USD Million) 2018 – 2032 53

FIG NO. 24. Canada DIABETES CARE DEVICES Market for Delivery, Revenue (USD Million) 2018 – 2032 54

FIG NO. 25. Canada DIABETES CARE DEVICES Market for Type 3, Revenue (USD Million) 2018 – 2032 55

FIG NO. 26. Canada DIABETES CARE DEVICES Market for Type 4, Revenue (USD Million) 2018 – 2032 56

FIG NO. 27. Canada DIABETES CARE DEVICES Market for Type 5, Revenue (USD Million) 2018 – 2032 57

FIG NO. 28. DIABETES CARE DEVICES Market Revenue Share, By Monitoring Devices , 2023 & 2032 59

FIG NO. 29. Market Attractiveness Analysis, By Monitoring Devices 60

FIG NO. 30. Incremental Revenue Growth Opportunity by Monitoring Devices , 2024 – 2032 60

FIG NO. 31. DIABETES CARE DEVICES Market Revenue, By Monitoring Devices , 2018, 2023, 2027 & 2032 61

FIG NO. 32. Canada DIABETES CARE DEVICES Market for Continuous Monitoring Devices, Revenue (USD Million) 2018 – 2032 62

FIG NO. 33. Canada DIABETES CARE DEVICES Market for Lancets, Revenue (USD Million) 2018 – 2032 63

FIG NO. 34. Canada DIABETES CARE DEVICES Market for Test Strips, Revenue (USD Million) 2018 – 2032 64

FIG NO. 35. Canada DIABETES CARE DEVICES Market for Self Monitoring Devices, Revenue (USD Million) 2018 – 2032 65

FIG NO. 36. Canada DIABETES CARE DEVICES Market for Monitoring Devices 5, Revenue (USD Million) 2018 – 2032 66

FIG NO. 37. DIABETES CARE DEVICES Market Revenue Share, By Delivery Devices , 2023 & 2032 68

FIG NO. 38. Market Attractiveness Analysis, By Delivery Devices 69

FIG NO. 39. Incremental Revenue Growth Opportunity by Delivery Devices , 2024 – 2032 69

FIG NO. 40. DIABETES CARE DEVICES Market Revenue, By Delivery Devices , 2018, 2023, 2027 & 2032 70

FIG NO. 41. Canada DIABETES CARE DEVICES Market for Insulin Pumps, Revenue (USD Million) 2018 – 2032 71

FIG NO. 42. Canada DIABETES CARE DEVICES Market for Pens, Revenue (USD Million) 2018 – 2032 72

FIG NO. 43. Canada DIABETES CARE DEVICES Market for Syringes, Revenue (USD Million) 2018 – 2032 73

FIG NO. 44. Canada DIABETES CARE DEVICES Market for Needles, Revenue (USD Million) 2018 – 2032 74

FIG NO. 45. Canada DIABETES CARE DEVICES Market for Delivery Devices 5, Revenue (USD Million) 2018 – 2032 75

FIG NO. 46. DIABETES CARE DEVICES Market Revenue Share, By End-Users, 2023 & 2032 77

FIG NO. 47. Market Attractiveness Analysis, By End-Users 78

FIG NO. 48. Incremental Revenue Growth Opportunity by End-Users, 2024 – 2032 78

FIG NO. 49. DIABETES CARE DEVICES Market Revenue, By End-Users, 2018, 2023, 2027 & 2032 79

FIG NO. 50. Canada DIABETES CARE DEVICES Market for Hospital Pharmacies, Revenue (USD Million) 2018 – 2032 80

FIG NO. 51. Canada DIABETES CARE DEVICES Market for Retail Pharmacies, Revenue (USD Million) 2018 – 2032 81

FIG NO. 52. Canada DIABETES CARE DEVICES Market for Online Pharmacies, Revenue (USD Million) 2018 – 2032 82

FIG NO. 53. DIABETES CARE DEVICES Market Revenue Share, By Indication Channel, 2023 & 2032 84

FIG NO. 54. Market Attractiveness Analysis, By Indication Channel 85

FIG NO. 55. Incremental Revenue Growth Opportunity by Indication Channel, 2024 – 2032 85

FIG NO. 56. DIABETES CARE DEVICES Market Revenue, By Indication Channel, 2018, 2023, 2027 & 2032 86

FIG NO. 57. Canada DIABETES CARE DEVICES Market for Diabetes Type I, Revenue (USD Million) 2018 – 2032 87

FIG NO. 58. Canada DIABETES CARE DEVICES Market for Diabetes Type II, Revenue (USD Million) 2018 – 2032 88

FIG NO. 59. Canada DIABETES CARE DEVICES Market for Gestational Diabetes, Revenue (USD Million) 2018 – 2032 89

FIG NO. 60. Canada DIABETES CARE DEVICES Market for Indication Channel 4, Revenue (USD Million) 2018 – 2032 90

FIG NO. 61. Canada DIABETES CARE DEVICES Market for Indication Channel 5, Revenue (USD Million) 2018 – 2032 91

FIG NO. 62. Research Methodology – Detailed View 100

FIG NO. 63. Research Methodology 101

List of Tables

TABLE NO. 1. : Canada DIABETES CARE DEVICES Market: Snapshot 18

TABLE NO. 2. : Drivers for the DIABETES CARE DEVICES Market: Impact Analysis 22

TABLE NO. 3. : Restraints for the DIABETES CARE DEVICES Market: Impact Analysis 24

TABLE NO. 4. : Canada DIABETES CARE DEVICES Market Revenue, By Type, 2018 – 2023 34

TABLE NO. 5. : Key Raw Materials & Suppliers 35

TABLE NO. 6. : Canada DIABETES CARE DEVICES Market Revenue, By Type, 2018 – 2023 (USD Million) 89

TABLE NO. 7. : Canada DIABETES CARE DEVICES Market Revenue, By Type, 2024 – 2032 (USD Million) 89

TABLE NO. 8. : Canada DIABETES CARE DEVICES Market Revenue, By Monitoring Devices , 2018 – 2023 (USD Million) 90

TABLE NO. 9. : Canada DIABETES CARE DEVICES Market Revenue, By Monitoring Devices , 2024 – 2032 (USD Million) 90

TABLE NO. 10. : Canada DIABETES CARE DEVICES Market Revenue, By Delivery Devices , 2018 – 2023 (USD Million) 91

TABLE NO. 11. : Canada DIABETES CARE DEVICES Market Revenue, By Delivery Devices , 2024 – 2032 (USD Million) 91

TABLE NO. 12. : Canada DIABETES CARE DEVICES Market Revenue, By End-Users, 2018 – 2023 (USD Million) 92

TABLE NO. 13. : Canada DIABETES CARE DEVICES Market Revenue, By End-Users, 2024 – 2032 (USD Million) 92

TABLE NO. 14. : Canada DIABETES CARE DEVICES Market Revenue, By Indication Channel, 2018 – 2023 (USD Million) 93

TABLE NO. 15. : Canada DIABETES CARE DEVICES Market Revenue, By Indication Channel, 2024 – 2032 (USD Million) 93

Frequently Asked Questions

What is the current size of the Canada Diabetes Care Devices Market?

The Canada Diabetes Care Devices market was valued at USD 1,209.55 million in 2023 and is projected to grow to USD 2,469.97 million by 2032, reflecting a compound annual growth rate (CAGR) of 7.86%.

What factors are driving the growth of the Canada Diabetes Care Devices Market?

Growth is driven by the increasing prevalence of diabetes, technological advancements in continuous glucose monitoring (CGM) systems and insulin pumps, rising awareness about diabetes management, supportive government initiatives, and the integration of smart devices with mobile apps for personalized healthcare solutions.

What are the key segments within the Canada Diabetes Care Devices Market?

The market is segmented into Monitoring Devices (Continuous Monitoring Devices, Lancets, Test Strips, and Self-Monitoring Devices) and Delivery Devices (Insulin Pumps, Pens, Syringes, and Needles). These are further categorized by End-Users (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) and Indications (Type 1 Diabetes, Type 2 Diabetes, and Gestational Diabetes).

What are some challenges faced by the Canada Diabetes Care Devices Market?

Key challenges include the high costs of advanced devices like CGM systems and insulin pumps, complex reimbursement processes, limited access to specialized care in rural areas, usability challenges with advanced devices, and concerns about data privacy and device durability.

Who are the major players in the Canada Diabetes Care Devices Market?

Major players include Abbott Laboratories, Medtronic, Roche Diagnostics, Dexcom, Johnson & Johnson, and Becton, Dickinson and Company. These companies are known for their advanced diabetes care solutions, including CGM systems, insulin pumps, and smart monitoring devices.

Purchase Options

Single User

$2699

Multi User

$3699

Custom Report

$5699

Request Free Sample

Have a question?

Don’t settle for less – trust Mitul to help you find the best solution.

Call: +91 6232 49 3207

EMAIL MITUL

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –